About Tatva Chintan Pharma
The shares listed at ₹2,111.85, a 95.00% move from the issue price. Tatva Chintan Pharma is a Mainboard IPO with an issue size of ₹500.00 crore, proposed for listing on BSE, NSE. The offer opens on 16th Jul 2021 and closes on 20th Jul 2021. The issue structure includes a fresh issue of ₹225.00 crore and an offer-for-sale component of ₹275.00 crore. The current listing schedule points to 29th Jul 2021.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/